Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

Advertising by Adpathway

New launches, chronic portfolio to maintain growth for Zydus Lifesciences

1 week ago 3

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

Advertising by Adpathway

Home / Companies / News / New launches, chronic portfolio to maintain growth for Zydus Lifesciences

Strong domestic formulations, chronic therapies, new US launches and a complex-product pipeline have supported the rally, though valuations now stand above historical averages

Zydus Lifesciences, Zydus

premium

At the current price of ₹1,145, the stock is trading at 25 times its FY28 earnings estimates, a premium to its five-year historical average

Ram Prasad Sahu

4 min read

Last Updated :

Oct 02 2026 | 2:53 PM

IST

The stock of Zydus Lifesciences, the country’s fourth-largest pharmaceutical company by market capitalisation, hit a two-year high, aided by a 33 per cent surge over the past six months.

Read Entire Article

Start the new Vibrations with a Medbed Franchise today!

Protect your whole family with Quantum Orgo-Life® devices

Advertising by Adpathway